ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of MP-214 in Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01625000
Recruitment Status : Completed
First Posted : June 21, 2012
Last Update Posted : September 27, 2016
Sponsor:
Information provided by (Responsible Party):
Mitsubishi Tanabe Pharma Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : October 2015